Scarica l'app Stockscreener
23.50
2.04%
-0.49
Syndax Pharmaceuticals Inc Azioni (SNDX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
49.83%
68.73
|
45.87 | 37.96 | 20.04 | 12.50 |
Operating Expenses
|
27.09%
131.28
|
103.30 | 107.31 | 103.80 | 102.08 |
| Benefits Costs and Expenses |
-321.03
|
- | - | 104.89 | - |
| Costs And Expenses |
20.43%
124.40
|
103.30 | 107.31 | 104.89 | 102.08 |
| Operating Income/Loss |
8.92%
-62.55
|
-57.43 | -69.35 | -83.76 | -89.58 |
| Nonoperating Income/Loss |
66.19%
-5.466
|
-3.289 | -2.494 | -1.089 | 5.451 |
| Income/Loss From Continuing Operations Before Tax |
749.69%
389.76
|
45.87 | -71.85 | -84.85 | 12.50 |
| Income Tax Expense/Benefit |
0.433
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
12.02%
-68.01
|
-60.72 | -71.85 | -84.85 | -84.13 |
|
Net Income/Loss
|
12.02%
-68.01
|
-60.72 | -71.85 | -84.85 | -84.13 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.89%
0.0944
|
86.62 | 86.34 | 86.17 | 85.43 |
| Diluted Average Shares |
99.89%
0.0944
|
86.62 | 86.34 | 86.17 | 85.43 |
| Basic Earnings Per Share |
11.43%
-0.78
|
-0.70 | -0.83 | -0.98 | -0.98 |
| Diluted Earnings Per Share |
11.43%
-0.78
|
-0.70 | -0.83 | -0.98 | -0.98 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):